Bronchiectasis Adult Clinical Trial
Official title:
Efficacy and Safety of Inhaled Tobramycin on Bronchiectasis Colonized With Pseudomonas Aeruginosa: A Randomized, Double-blind, Parallel-group Multicenter Trial
This is a phase 3 study. Patients will be enrolled from 14 medical centers in mainland China. Eligible patients will be randomly allocated to treatment group (tobramycin nebulization, 300mg bid) and control group (natural saline nebulization, 5ml bid). A total of two 28-day on-and-off cycles will be scheduled. Both tobramycin solution and natural saline and the nebulizer will be solely provided by the sponsor.
This is a phase 3 study. All bronchiectasis patients will be enrolled from 14 medical centers located in different geographic regions of mainland China. After a three-week screening period, On the basis of usual care [ambroxool (30mg thrice daily) or N-acetylcysteine (0.2g thrice daily) and chest physiotherapy (5 min, once daily)], eligible patients will be randomly allocated to treatment group (tobramycin nebulization, 300mg bid, delivered via an ultrasonic nebulizer) and control group (natural saline nebulization, 5ml bid, delivered via an ultrasonic nebulizer). A total of two 28-day on-and-off cycles will be scheduled. At the end of each on-and-off cycle, sputum culture and other clinical assessments will be performed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04142827 -
The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
|
N/A | |
| Recruiting |
NCT06093191 -
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
|
Phase 4 | |
| Not yet recruiting |
NCT04509661 -
Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
|
Phase 4 | |
| Recruiting |
NCT06017739 -
Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis
|
N/A | |
| Completed |
NCT04435327 -
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
|
||
| Recruiting |
NCT03696290 -
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
|
Phase 2 | |
| Not yet recruiting |
NCT05068518 -
The Role of Airway Microbiota on Clinical Phenotypes and Disease Severity in Bronchiectasis
|
||
| Recruiting |
NCT04658277 -
Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
|
N/A | |
| Completed |
NCT04744220 -
Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis
|
N/A | |
| Completed |
NCT05764343 -
The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases
|
N/A | |
| Recruiting |
NCT05582798 -
Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
|
Phase 4 | |
| Not yet recruiting |
NCT04987827 -
Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients
|
||
| Recruiting |
NCT03791086 -
The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping
|
||
| Completed |
NCT04234789 -
Predictors of Physical Activity Performance and Dynamic Hyperinflation in Patients With Bronchiectasis
|
N/A | |
| Recruiting |
NCT04865861 -
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation
|
||
| Completed |
NCT04742270 -
Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis)
|
N/A | |
| Recruiting |
NCT05330637 -
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
|
||
| Completed |
NCT05989360 -
The Utility of Lung Clearance Index in Ethnic Groups and in Disease
|
N/A | |
| Completed |
NCT03125174 -
Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
|
N/A | |
| Active, not recruiting |
NCT04102774 -
Effect of AIRVO Heated Humidification in Bronchiectasis
|
N/A |